Effect of a monoclonal antibody against human relaxin-2 on cancer cell growth inhibition

Applied Biological Chemistry

Volumn 59, Issue 5, 2016, Pages 739-746

  Park, Byoung Kwon ^a   Lee, Su In ^a   Lee, Younghee ^b   Cho, Sooyoung ^c   Lee, Young Seek ^d   Kwon, Hyung Joo ^a  

^a Hallym University College of Medicine   (South Korea)

^b Chungbuk National University   (South Korea)

^c Seoul National University   (South Korea)

^d Hanyang University   (South Korea)

Author keywords

Cancer; Monoclonal antibody; Relaxin 2

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; DISEASES;

ANGIOGENESIS; CANCER; CANCER CELL GROWTH; CANCER CELL LINES; CANCER CELLS; CANCER THERAPEUTICS; EPITOPE PEPTIDE; GROWTH INHIBITION; IMMUNOPRECIPITATION ANALYSIS; RELAXIN-2;

MONOCLONAL ANTIBODIES;

EID: 84982270146     PISSN: 24680834     EISSN: 24680842     Source Type: Journal    
DOI: 10.1007/s13765-016-0221-4     Document Type: Article

References (28)

1. Bani D, Flagiello D, Poupon MF, Nistri S, Poirson-Bichat F, Bigazzi M, Bani Sacchi T (1999) Relaxin promotes differentiation of human breast cancer cells MCF-7 transplanted into nude mice. Virchows Arch 435:509–519
2. Binder C, Simon A, Binder L, Hagemann T, Schulz M, Emons G, Trümper L, Einspanier A (2004) Elevated concentrations of serum relaxin are associated with metastatic disease in breast cancer patients. Breast Cancer Res Treat 87:157–166
3. Binder C, Chuang E, Habla C, Bleckmann A, Schulz M, Bathgate R, Einspanier A (2014) Relaxins enhance growth of spontaneous murine breast cancers as well as metastatic colonization of the brain. Clin Exp Metastasis 31:57–65
4. De Meyts P (2004) Insulin and its receptor: structure, function and evolution. BioEssays 26:1351–1362
5. Feng S, Agoulnik IU, Bogatcheva NV, Kamat AA, Kwabi-Addo B, Li R, Ayala G, Ittmann MM, Agoulnik AI (2007) Relaxin promotes prostate cancer progression. Clin Cancer Res 13:1695–1702
6. Feng S, Agoulnik IU, Li Z, Han HD, Lopez-Berestein G, Sood A, Ittmann MM, Agoulnik AI (2009) Relaxin/RXFP1 signaling in prostate cancer progression. Ann N Y Acad Sci 1160:379–380
7. Feng S, Agoulnik IU, Truong A, Li Z, Creighton CJ, Kaftanovskaya EM, Pereira R, Han HD, Lopez-Berestein G, Klonisch T, Ittmann MM, Sood AK, Agoulnik AI (2010) Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis. Endocr Relat Cancer 17:1021–1033
8. Huang H, Zheng HY, Liu ZL, Zhang L (2014) Prognostic significance of relaxin-2 and S100A4 expression in osteosarcoma. Eur Rev Med Pharmacol Sci 18:2828–2834
9. Kim D, Kwon S, Ahn CS, Lee Y, Choi SY, Park J, Kwon HY, Kwon HJ (2011) Adjuvant effect of liposome-encapsulated natural phosphodiester CpG-DNA. BMB Rep 44:758–763
10. Kim TH, Kim D, Lee Y, Kwon HJ (2014) Expression of UNC93A induced by CpG-DNA-liposome complex in mice. J Korean Soc Appl Biol Chem 57:281–287
11. Kim D, Lee Y, Kwon HJ (2015) Production of epitope-specific antibodies by immunization with synthetic epitope peptide formulated with CpG-DNA-liposome complex without carriers. Meth Mol Biol 1348:127–135
12. Klinman DM, Currie D, Gursel I, Verthelyi D (2004) Use of CpG oligodeoxynucleotides as immune adjuvants. Immunol Rev 199:201–216
13. Lee KW, Jung J, Lee Y, Kim TY, Choi SY, Park J, Kim DS, Kwon HJ (2006) Immunostimulatory oligodeoxynucleotide isolated from genome wide screening of Mycobacterium bovis chromosomal DNA. Mol Immunol 43:2107–2118
14. Lenhart JA, Ryan PL, Ohleth KM, Palmer SS, Bagnell CA (2001) Relaxin increases secretion of matrix metalloproteinase-2 and matrix metalloproteinase-9 during uterine and cervical growth and remodeling in the pig. Endocrinology 142:3941–3949
15. Lenhart JA, Ryan PL, Ohleth KM, Palmer SS, Bagnell CA (2002) Relaxin increases secretion of tissue inhibitor of matrix metalloproteinase-1 and -2 during uterine and cervical growth and remodeling in the pig. Endocrinology 143:91–98
16. Nair VB, Samuel CS, Separovic F, Hossain MA, Wade JD (2012) Human relaxin-2: historical perspectives and role in cancer biology. Amino Acids 43:1131–1140
17. Ohleth KM, Lenhart JA, Ryan PL, Radecki SV, Bagnell CA (1997) Relaxin increases insulin-like growth factors (IGFs) and IGF-binding proteins of the pig uterus in vivo. Endocrinology 138:3652–3658
18. Park BK, Kim D, Wu G, Choi SH, Kim DS, Lee Y, Kwon HJ (2014) Effect of epitope-CpG-DNA-liposome complex without carriers on vaccination of respiratory syncytial virus infection. J Korean Soc Appl Biol Chem 57:667–676
19. Park BK, Choi SH, Kim YE, Park S, Lee Y, Lee KW, Kwon HJ (2015) Monoclonal antibodies against the human respiratory syncytial virus obtained by immunization with epitope peptides and CpG-DNA-liposome complex. Monoclon Antib Immunodiagn Immunother 34:101–109
20. Radestock Y, Hoang-Vu C, Hombach-Klonisch S (2008) Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells. Breast Cancer Res 10:R71
21. Ren XF, Zhao H, Gong XC, Wang LN, Ma JF (2015) RLN2 regulates in vitro invasion and viability of osteosarcoma MG-63 cells via S100A4/MMP-9 signal. Eur Rev Med Pharmacol Sci 19:1030–1036
22. Shabanpoor F, Separovic F, Wade JD (2009) The human insulin superfamily of polypeptide hormones. Vitam Horm 80:1–31
23. Shang SB, Jin YL, Jiang XT, Zhou JY, Zhang X, Xing G, He JL, Yan Y (2009) Fine mapping of antigenic epitopes on capsid proteins of porcine circovirus, and antigenic phenotype of porcine circovirus type 2. Mol Immunol 46:327–334
24. Silvertown JD, Summerlee AJ, Klonisch T (2003) Relaxin-like peptides in cancer. Int J Cancer 107:513–519
25. Silvertown JD, Ng J, Sato T, Summerlee AJ, Medin JA (2006) H2 relaxin overexpression increases in vivo prostate xenograft tumor growth and angiogenesis. Int J Cancer 118:62–73
26. Tashima LS, Mazoujian G, Bryant-Greenwood GD (1994) Human relaxins in normal, benign and neoplastic breast tissue. J Mol Endocrinol 12:351–364
27. Thompson VC, Morris TG, Cochrane DR, Cavanagh J, Wafa LA, Hamilton T, Wang S, Fazli L, Gleave ME, Nelson CC (2006) Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgens. Prostate 66:1698–1709
28. Unemori EN, Lewis M, Constant J, Arnold G, Grove BH, Normand J, Deshpande U, Salles A, Pickford LB, Erikson ME, Hunt TK, Huang X (2000) Relaxin induces vascular endothelial growth factor expression and angiogenesis selectively at wound sites. Wound Repair Regen 8:361–370